CompletedNCT00034580
Olanzapine or risperidone for bipolar I mood episodes
About this title
Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
Read the official source — NCT00034580Medication studyAges 18–70United StatesBipolarity
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
- Listed locations
- Berkley and 20 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 2001
- Recruitment status
- Completed
- Enrollment listed in the registry
- 326
- Sponsor
- Eli Lilly and Company
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT00034580
- Official title
Show the full official title
Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Berkley · Los Angeles · Orange
18 more locations
- San Marcos
- Torrance
- Denver
- Middleton
- Washington D.C.
- Winter Park
- Boise
- Hoffman Estates
- Natick
- St Louis
- Las Vegas
- Clementon
- Olean
- Philadelphia
- Madison
- Houston
- Richmond
- Roanoke
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Eli Lilly and Company.
Did this study involve medication?
Yes. The study involved medication, including olanzapine and risperidone.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 18 years to 70 years. Other eligibility criteria applied.
